This comparison is now largely academic — Ozempic has been restricted for weight loss since October 2024. But if you're deciding between a cheap short-term option and a GLP-1, here's the full picture plus your actual alternatives.
Note: Ozempic is restricted for weight loss since October 2024. For a more relevant comparison, see Injections vs Tablets or compare Duromine with the available GLP-1 options (Wegovy, Mounjaro).
| Duromine | Ozempic | |
|---|---|---|
| Type | Daily tablet | Weekly injection |
| Mechanism | CNS stimulant | GLP-1 agonist |
| Duration | 12 weeks maximum | Long-term |
| Avg. weight loss | 5–10% | ~15% |
| Monthly cost | ~$100 | $130–190 |
| Available for weight loss? | Yes | Restricted |
Since Ozempic isn't available for weight loss, your realistic choices are:
Many patients start with Duromine as a 12-week kickstart, then transition to Wegovy or Mounjaro for long-term management.
This comparison is now mostly academic because Ozempic is restricted for weight loss. But the underlying question — "should I choose a cheap short-term option or an expensive long-term one?" — remains relevant. The realistic version of this comparison today is Duromine vs Wegovy or Duromine vs Mounjaro.
A popular approach: start with Duromine ($100/month for 12 weeks) as a low-cost trial of medication-assisted weight loss. If it works and you want to continue, transition to a GLP-1 medication (Wegovy or Mounjaro) for long-term management. This lets you test the concept for $300 total before committing to $400+/month ongoing.